HER2 Support Group Forums - View Single Post

Sandra in GA · 05-14-2010, 04:17 PM

Ellie,

There is a Walter Reed vaccine study going on in the US, Greece, and Germany. This tiral is using two second generation peptide vaccines. There is something for everybody if you are NED and no more that six months out from your last treatment, Herceptin or chemo.

Arm I: HLA-A2-positive patients receive GP2 peptide/GM-CSF vaccine intradermally (ID) every 3-4 weeks for a total of up to 6 inoculations. HLA-A2-negative patients receive AE37 peptide/GM-CSF vaccine ID every 3-4 weeks for a total of up to 6 inoculations.
Arm II : Patients receive GM-CSF ID every 3-4 weeks for a total of up to 6 inoculations.

I am currently in this trial at Winston-Salen North Carolina and know for a fact they still have a number of openings. The other locations are:

Walter Reed Army Medical Center
Washington DC
Contact: Diane Papay, RN 202-782-3877

Wale Forest University Comprehensive Cancer Center
Winston-Salem North Carolina
Contact: Robin Petro, RN 336-713-4788

Germany
Landstuhl Regional Medical Center
Landstuhl, Germany, 66840
Contact: Mark G. Carmichael, MD 49-6371-86-8100

Greece
Saint Savas Cancer Hospital of Athens
Athens, Greece, 11522
Contact: Michael Papamichail, MD 30-210-6409-624

I hope this helps you. Good luck.
Sandra

05-14-2010, 04:17 PM	#4
Sandra in GA Senior Member Join Date: Aug 2009 Location: Moultrie, GA Posts: 431	Re: Sloan Kettering her 2 vaccine trial Ellie, There is a Walter Reed vaccine study going on in the US, Greece, and Germany. This tiral is using two second generation peptide vaccines. There is something for everybody if you are NED and no more that six months out from your last treatment, Herceptin or chemo. Arm I: HLA-A2-positive patients receive GP2 peptide/GM-CSF vaccine intradermally (ID) every 3-4 weeks for a total of up to 6 inoculations. HLA-A2-negative patients receive AE37 peptide/GM-CSF vaccine ID every 3-4 weeks for a total of up to 6 inoculations. Arm II : Patients receive GM-CSF ID every 3-4 weeks for a total of up to 6 inoculations. I am currently in this trial at Winston-Salen North Carolina and know for a fact they still have a number of openings. The other locations are: Walter Reed Army Medical Center Washington DC Contact: Diane Papay, RN 202-782-3877 Wale Forest University Comprehensive Cancer Center Winston-Salem North Carolina Contact: Robin Petro, RN 336-713-4788 Germany Landstuhl Regional Medical Center Landstuhl, Germany, 66840 Contact: Mark G. Carmichael, MD 49-6371-86-8100 Greece Saint Savas Cancer Hospital of Athens Athens, Greece, 11522 Contact: Michael Papamichail, MD 30-210-6409-624 I hope this helps you. Good luck. Sandra __________________ Diagnosed: 7/25/08 ~ age 63, no family history Surgery: 8/14/08 Bilateral mastectomy; tumor left breast, node dissection; right prophylactic with expanders: 1/12/10 latisimuss dorsi flap on left side: 9/22/10 implants in Pathology Report: ER/PR-; HER2+ (3+); Grade 3, StageIII; 3cm tumor plus 21/21 lymph nodes positive; 5cm DCIS Chemo: A/C; Taxol/Herceptin/Tykerb; phase II study at Mayo adding Tykerb for early stage Radiation: 25 rads Vaccine: Walter Reed GP2/AE37 vaccine study ~ last booster 9/17/2012